The potential approval of Vertex’s IgAN therapy povetacicept in 2026 comes amid launch headwinds for the company’s non-opioid ...

Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and ...

Mr. Brady became the latest celebrity to try to preserve a pet’s genetics, a move that animal rights groups have criticized.

An update from Karolinska Development AB ( ($SE:KDEV) ) is now available. Karolinska Development’s portfolio company, Modus Therapeutics, has ...

Here are the top stories we're following around The Big Bend, South Georgia, Nationally, and your Tuesday forecast.

Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of ...

We learned that Smokey X was diagnosed with a type of kidney cancer. He is not the first in the long line of hounds to get a diagnosis like this.

Apellis expects EMPAVELI launch metrics to be measured by patient start forms, projecting 225 cumulative start forms or more by the end of 2025. Management reiterated, "We believe we have worked ...

STOCKHOLM, SWEDEN November 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has received regulatory approval to initiate the ...

A Glocester, Rhode Island farm discovered their well water is contaminated with PFAS, or "forever chemicals," at levels ten ...